• September 6, 2019  

    What Questions Should I Ask My Doctor?

    Cancer Commons ScientistsSarah Stanley

    When faced with an advanced cancer diagnosis, it can be difficult to know what questions to ask. At Cancer Commons, we help patients and caregivers navigate a vast sea of cancer information so they can work with their doctor to pinpoint their best possible treatment plan. Based on our Scientists’ many years of experience helping patients and caregivers around the world, here are some… Read more »

  • August 17, 2019  

    Non-Hodgkin Lymphoma—Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Malignancies of lymphoid tissues are broadly named “lymphoma.” There are many categories and subcategories. Here is a broadly based report about non-Hodgkin lymphomas, published by Medscape in 2019.

     

  • August 17, 2019  

    Diffuse Intrinsic Pontine Glioma (DIPG)—An Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    DIPG is a rare, malignant brain tumor. Three hundred Americans, usually children, are diagnosed with DIPG each year. Its location (pons), its sublocation (intrinsic), its growth character (diffuse), and its cell type (glioma) describe a very difficult cancer to treat. Here is how one prestigious cancer center (Dana-Farber Cancer Institute) explains DIPG.

    .

  • August 17, 2019  

    Malignant Melanoma—An Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Malignant melanoma is a fairly common, usually cutaneous, potentially lethal malignancy, and precision oncology has demonstrated some dramatic successes for treatment of its advanced stages. If you wish to learn more, this 2019 encyclopedic discourse from Medscape is solid, current, unbiased, and sensible.
  • August 15, 2019  

    Comparison of Scans for Detection of Early Biochemical Recurrence of Prostate Cancer After Prostatectomy Bookmark

    George Lundberg, MD

    Article from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:

    Most prostate cancers don’t hurt the patient. Surgery for high-risk prostate cancer can be beneficial. If the cancer recurs, more treatment could be helpful. This study provides useful information about detection of recurrence.

    Go to full article published by The ASCO Post.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

     

  • August 9, 2019  

    Patients with Newly Diagnosed Brain Tumors Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    Receiving a brain tumor diagnosis can be shocking for patients and their families. The Musella Foundation’s free “Brain Tumor Guide for the Newly Diagnosed” provides up-to-date guidance for people in this difficult position.

    .

  • August 5, 2019  

    Navigating Pancreatic Cancer—The Basics

    With: Lola Rahib, PhD

    A Q&A with Lola Rahib, PhD, Lead Scientist, Pancreas Cancer, at Cancer Commons, Los Altos, CA; lola.rahib@cancercommons.org Q: Navigating a pancreatic cancer diagnosis can be overwhelming and confusing for patients and their loved ones. How can patients and their caregivers ensure having the knowledge, support, and plan they need to be able to navigate treatment options and other aspects of the disease? A: Patients… Read more »

  • May 21, 2019  

    Can You Improve Your Response to Certain Immunotherapy Drugs?

    Emma Shtivelman, PhD

    Cancer treatments that use a strategy called immune checkpoint blockade (ICB) have entered clinical practice in a big way, with six drugs now approved by the U.S. Food and Drug Administration (FDA) for a variety of cancers. These drugs release “brakes” on the immune system, boosting its ability to kill cancer cells. Specifically, they target the proteins PD-1 or CTLA-4, which are found on… Read more »

  • March 19, 2019  

    At Diagnosis, What Do Cancer Patients Want?

    With: Laura Benson, RN, MS, ANP

    A Q&A with Laura Benson, RN, MS, ANP, president of Conversations in Care, LLC; LauraBensonRN@Gmail.com Q: In our digital communication world of 2019, some patients may receive the initial message that YOU HAVE CANCER by cell phone, text, email, or even voice mail. When this happens, what do patients most want, and how can that best be accomplished? A: When I first read your question, I… Read more »

  • October 1, 2018  

    What to Expect When Active Surveillance Leads to Prostatectomy Bookmark

    Emma Shtivelman, PhD

    Excerpt from MedPage Today:

    “A high proportion of men who entered active surveillance for early prostate cancer had one or more high-risk disease characteristics when they subsequently had radical prostatectomy, a Swedish study showed.

    “Medical records showed that 52 of 132 men had at least one adverse pathology feature at radical prostatectomy. All the men initially opted for active surveillance, and the median time from enrollment to surgery was 1.9 years.”

    Go to full article published by MedPage Today on Sep 21, 2018.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.